Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples